Hao Jiang

Shandong University

H指数:16

被引数:1,104

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ALDH3A2 targets arachidonic acid to promote cell metastasis in TNBC via AMPK/m-TOR signaling pathway

ALDH3A2通过AMPK/m-TOR信号通路靶向花生四烯酸以促进TNBC细胞转移

Breast Cancer Research

IF5.6

2025-12-180

OAAI

Stability Assessment of Surrounding Rock during Shield Tunneling through Karst Cavities Using Numerical and Physical Modeling

Geotechnical and Geological Engineering

IF2

2025-10-311

PRE

Targeted Reprogramming of TREM2-Positive Macrophages and MRI-Guided Immune Monitoring in Colorectal Cancer Using CSF1R@Mn@MPDA-Antitrem2 Nanoplatform

靶向重编程TREM2阳性巨噬细胞及MRI引导的免疫监测在结直肠癌中的应用：CSF1R@Mn@MPDA-Anti-Trem2纳米平台

Advanced Healthcare Materials

IF9.6

2025-05-260

PRE

Dysfunction in neuro-mesenchymal units impairs the development of bone marrow B cells in mice with anxiety

神经间充质单位的功能障碍损害了焦虑小鼠骨髓B细胞的发育。

BRAIN BEHAVIOR AND IMMUNITY

IF7.6

2025-02-010

OAAI

Calothrixin B by docking JAK2 is a potential therapeutic inhibitor for pancreatic ductal adenocarcinoma

Calothrixin B通过结合JAK2，是胰腺导管腺癌的一种潜在的治疗性抑制剂。

JOURNAL OF PHARMACY AND PHARMACOLOGY

IF3.2

2025-01-230

PRE

Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway

MOLECULAR MEDICINE

IF6.4

2024-05-173

OAAI

Targeting C21orf58 is a Novel Treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of JAK2/C21orf58/STAT3 Complex

靶向C21orf58通过破坏JAK2/C21orf58/STAT3复合物的形成是一种新的肝细胞癌治疗策略

ADVANCED SCIENCE

IF14.1

2024-02-112

OAAI

STAT5a and SH2B3 novel mutations display malignancy roles in a triple-negative primary myelofibrosis patient

CANCER GENE THERAPY

IF5

2023-12-220

PRE

Deep Learning to Predict the Cell Proliferation and Prognosis of Non-Small Cell Lung Cancer Based on FDG-PET/CT Images

基于fdg-pet/CT图像的深度学习预测非小细胞肺癌细胞增殖及预后

DIAGNOSTICS

IF3.3

2023-09-308

OAAI

Photothermal-Starvation Therapy Nanomodulator Capable of Inhibiting Colorectal Cancer Recurrence and Metastasis by Energy Metabolism Reduction

光热饥饿疗法纳米调节剂通过降低能量代谢抑制结直肠癌复发转移

ADVANCED HEALTHCARE MATERIALS

IF9.6

2023-08-135

PRE

Immunostimulant nanomodulator boosts antitumor immune response in triple negative breast cancer by synergism of vessel normalization and photothermal therapy

免疫刺激纳米调节剂通过血管正常化和光热治疗的协同作用增强三阴性乳腺癌的抗肿瘤免疫反应

NANO RESEARCH

IF9

2023-05-293

PRE

PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1

PPDPF通过调节SOS1的GEF活性促进突变KRAS驱动的胰腺导管腺癌的发展

ADVANCED SCIENCE

IF14.1

2022-12-014

Nestin plus Peyer's patch resident MSCs enhance healing of inflammatory bowel disease through IL-22-mediated intestinal epithelial repair

CELL PROLIFERATION

IF5.6

2022-11-2010

OAAI

ARID2 mitigates hepatic steatosis via promoting the ubiquitination of JAK2

CELL DEATH AND DIFFERENTIATION

IF15.4

2022-11-178

Effect of Information Framing on Wearing Masks During the COVID-19 Pandemic: Interaction With Social Norms and Information Credibility

FRONTIERS IN PUBLIC HEALTH

IF3.4

2022-02-239

OAAI

The Uptake and Vaccination Willingness of COVID-19 Vaccine among Chinese Residents: Web-Based Online Cross-Sectional Study

VACCINES

IF3.4

2022-01-0814

OAAI

PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling

NATURE COMMUNICATIONS

IF15.7

2021-05-2426

OAAI

Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis

染色质重塑因子ARID2通过DNMT1-Snail轴抑制肝癌转移

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2020-02-1883

OAAI

BMP10 suppresses hepatocellular carcinoma progression via PTPRS-STAT3 axis

ONCOGENE

IF7.3

2019-08-1513

PREAI

CHML promotes liver cancer metastasis by facilitating Rab14 recycle

NATURE COMMUNICATIONS

IF15.7

2019-06-0735

OAAI

Hao Jiang

个人简介

教育背景

工作经历

荣誉奖项

研究方向